This is to inform you that the Board of Directors at their meeting held on 06.02.2026 had inter alia approved 1. Unaudited Standalone Financial Results of the company for the quarter ended ....
KOVAI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Kovai Medical Center & Hospital Ltd, meeting on 6 February 2026, approved the unaudited standalone financial results for the quarter and nine months ended 31 December 2025. Revenue from operations for Q3 FY26 rose to ₹40,661.98 lakhs from ₹35,469.58 lakhs in Q3 FY25, a growth of about 14.6%. For the nine-month period, revenue grew to ₹1,17,095.23 lakhs from ₹1,01,310.12 lakhs, up roughly 15.6%. Profit after tax for Q3 stood at ₹6,501.99 lakhs (vs ₹5,780.37 lakhs) and for nine months at ₹18,110.68 lakhs (vs ₹15,424.60 lakhs), with EPS at ₹59.42 and ₹165.51 respectively. The auditor, VKS Aiyer & Co, issued an unmodified limited review report with no qualifications or emphasis of matter.
Steady double-digit growth in both revenue and profit, along with a clean auditor review, signals operational momentum at KMCH and is mildly positive for shareholders. No negative flags such as restatement, auditor change, or exceptional items were raised in this filing.